A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

Clinical trial NCT02641002 · TERMINATED

Trial details

NCT number: NCT02641002
Sponsor: Celgene
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute Myelodysplastic Syndromes

Start date: 2016-03-01
Primary completion: 2018-07-18
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.